CAS: 2201056-66-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | AG-270 REF: AN-AG01V79KCAS: 2201056-66-6 | 97% | To inquire | Wed 02 Oct 24 |
 | AG-270 REF: TM-T9050CAS: 2201056-66-6 | 98.2% - 98.28% | 108.00 €~2,535.00 € | Wed 09 Oct 24 |
 | AG-270 REF: 3D-BND05666CAS: 2201056-66-6 | Min. 95% | To inquire | Wed 27 Nov 24 |
Ref: AN-AG01V79K
| 10mg | 167.00 € | ||
| 25mg | 237.00 € | ||
| 50mg | 284.00 € | ||
| 100mg | 612.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Wednesday 2 Oct 2024
AG-270
CAS:2201056-66-6
AG-270 is an allosteric and orally active inhibitor of MAT2A.
Formula:
C30H27N5O2
Purity:
98.2% - 98.28%
Color and Shape:
Solid
Molecular weight:
489.57
Ref: TM-T9050
| 1mg | 108.00 € | ||
| 5mg | 253.00 € | ||
| 10mg | 404.00 € | ||
| 25mg | 665.00 € | ||
| 50mg | 917.00 € | ||
| 100mg | 1,277.00 € | ||
| 500mg | 2,535.00 € |
Estimated delivery in United States, on Wednesday 9 Oct 2024
AG-270
CAS:2201056-66-6
AG-270 is a small molecule that binds to the extracellular domain of the human angiotensin …
Formula:
C30H31N5O2
Purity:
Min. 95%
Molecular weight:
493.6 g/mol
Ref: 3D-BND05666
| 5mg | 128.00 € | ||
| 10mg | 184.00 € | ||
| 25mg | 287.00 € | ||
| 50mg | 431.00 € | ||
| 100mg | 624.00 € |
Estimated delivery in United States, on Wednesday 27 Nov 2024
